Membrane-bound proteinase 3 and its receptors: Relevance for the pathogenesis of Wegener's Granulomatosis

Autoimmunity Reviews

Volumn 8, Issue 6, 2009, Pages 510-514

  Hu, Nan ^a   Westra, Johanna ^a   Kallenberg, Cees G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

2 integrin; ANCA; CD177; Fc RIIIb; Proteinase 3

Indexed keywords

CD177 ANTIGEN; LYMPHOCYTE ANTIGEN; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE 3 RECEPTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

HUMAN; LEUKOCYTE ACTIVATION; NEUTROPHIL; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; VASCULAR NECROSIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIGEN-ANTIBODY COMPLEX; BLOOD VESSELS; HUMANS; ISOANTIGENS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MYELOBLASTIN; NECROSIS; NEUTROPHIL ACTIVATION; NEUTROPHILS; RECEPTORS, CELL SURFACE; RECEPTORS, IGG; WEGENER GRANULOMATOSIS;

EID: 65549114466     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.01.003     Document Type: Review

References (36)

1. Witko-Sarsat V., Cramer E.M., Hieblot C., Guichard J., Nusbaum P., Lopez S., et al. Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood 94 (1999) 2487-2496
2. Halbwachs-Mecarelli L., Bessou G., Lesavre P., Lopez S., and Witko-Sarsat V. Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett 374 (1995) 29-33
3. Kallenberg C.G., Heeringa P., and Stegeman C.A. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2 (2006) 661-670
4. Jennette J.C., and Falk R.J. Small-vessel vasculitis. N Engl J Med 337 (1997) 1512-1523
5. Schreiber A., Luft F.C., and Kettritz R. Membrane proteinase 3 expression and ANCA-induced neutrophil activation. Kidney Int 65 (2004) 2172-2183
6. Segelmark M., Elzouki A.N., Wieslander J., and Eriksson S. The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 48 (1995) 844-850
7. Reumaux D., Vossebeld P.J., Roos D., and Verhoeven A.J. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86 (1995) 3189-3195
8. Hellmich B., Csernok E., Trabandt A., Gross W.L., and Ernst M. Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro. Clin Exp Immunol 120 (2000) 392-398
9. Csernok E., Szymkowiak C.H., Mistry N., Daha M.R., Gross W.L., and Kekow J. Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin Exp Immunol 105 (1996) 104-111
10. Schreiber A., Busjahn A., Luft F.C., and Kettritz R. Membrane expression of proteinase 3 is genetically determined. J Am Soc Nephrol 14 (2003) 68-75
11. Van Rossum A.P., Huitema M.G., Stegeman C.A., Bijl M., de Leeuw K., Van Leeuwen M.A., et al. Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls. Ann Rheum Dis 66 (2007) 1350-1355
12. Witko-Sarsat V., Lesavre P., Lopez S., Bessou G., Hieblot C., Prum B., et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 10 (1999) 1224-1233
13. Rarok A.A., Stegeman C.A., Limburg P.C., and Kallenberg C.G. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 13 (2002) 2232-2238
14. Gencik M., Meller S., Borgmann S., and Fricke H. Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int 58 (2000) 2473-2477
15. Abdgawad M., Hellmark T., Gunnarsson L., Westman K.W., and Segelmark M. Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism. Clin Exp Immunol 145 (2006) 63-70
16. Vietinghoff S., Busjahn A., Schonemann C., Massenkeil G., Otto B., Luft F.C., et al. Major histocompatibility complex HLA region largely explains the genetic variance exercised on neutrophil membrane proteinase 3 expression. J Am Soc Nephrol 17 (2006) 3185-3191
17. Cowland J.B., and Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leukoc Biol 66 (1999) 989-995
18. Yang J.J., Pendergraft W.F., Alcorta D.A., Nachman P.H., Hogan S.L., Thomas R.P., et al. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. J Am Soc Nephrol 15 (2004) 2103-2114
19. Goldmann W.H., Niles J.L., and Arnaout M.A. Interaction of purified human proteinase 3 (PR3) with reconstituted lipid bilayers. Eur J Biochem 261 (1999) 155-162
20. David A., Kacher Y., Specks U., and Aviram I. Interaction of proteinase 3 with CD11b/CD18 (beta2 integrin) on the cell membrane of human neutrophils. J Leukoc Biol 74 (2003) 551-557
21. David A., Fridlich R., and Aviram I. The presence of membrane Proteinase 3 in neutrophil lipid rafts and its colocalization with FcgammaRIIIb and cytochrome b558. Exp Cell Res 308 (2005) 156-165
22. Vietinghoff S., Tunnemann G., Eulenberg C., Wellner M., Cristina C.M., Luft F.C., et al. NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. Blood 109 (2007) 4487-4493
23. Stroncek D.F., Caruccio L., and Bettinotti M. CD177: A member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera. J Transl Med 2 (2004) 8
24. Hu N., Westra J., Huitema M.J., Bijl M., Brouwer E., Stegeman C.A., et al. Co-expression of CD177 and membrane proteinase 3 on neutrophils in ANCA-associated vasculitis: anti-PR3 mediated neutrophil activation is independent of CD177 expression. ACR/ARHP Annual Scientific Meeting, Abstract number: 1863 (28th Oct, 2008)
25. Vietinghoff S., Eulenberg C., Wellner M., Luft F.C., and Kettritz R. Neutrophil surface presentation of the anti-neutrophil cytoplasmic antibody-antigen proteinase 3 depends on N-terminal processing. Clin Exp Immunol 152 (2008) 508-516
26. Korkmaz B., Kuhl A., Bayat B., Santoso S., and Jenne D.E. A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener's granulomatosis, mediates membrane binding via NB1-receptors. J Biol Chem 283 (2008) 35976-35982
27. Campbell E.J., and Owen C.A. The sulfate groups of chondroitin sulfate- and heparan sulfate-containing proteoglycans in neutrophil plasma membranes are novel binding sites for human leukocyte elastase and cathepsin G. J Biol Chem 282 (2007) 14645-14654
28. Hajjar E., Mihajlovic M., Witko-Sarsat V., Lazaridis T., and Reuter N. Computational prediction of the binding site of proteinase 3 to the plasma membrane. Proteins 71 (2008) 1655-1669
29. Kantari C., Pederzoli-Ribeil M., mir-Moazami O., Gausson-Dorey V., Moura I.C., Lecomte M.C., et al. Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis. Blood 110 (2007) 4086-4095
30. Rarok A.A., Limburg P.C., and Kallenberg C.G. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 74 (2003) 3-15
31. Kocher M., Siegel M.E., Edberg J.C., and Kimberly R.P. Cross-linking of Fc gamma receptor IIa and Fc gamma receptor IIIb induces different proadhesive phenotypes on human neutrophils. J Immunol 159 (1997) 3940-3948
32. Kissel K., Santoso S., Hofmann C., Stroncek D., and Bux J. Molecular basis of the neutrophil glycoprotein NB1 (CD177) involved in the pathogenesis of immune neutropenias and transfusion reactions. Eur J Immunol 31 (2001) 1301-1309
33. Simon D.I., Wei Y., Zhang L., Rao N.K., Xu H., Chen Z., et al. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J Biol Chem 275 (2000) 10228-10234
34. Tang M.L., Vararattanavech A., and Tan S.M. Urokinase-type plasminogen activator receptor induces conformational changes in the integrin alphaMbeta2 headpiece and reorientation of its transmembrane domains. J Biol Chem 283 (2008) 25392-25403
35. May A.E., Neumann F.J., Schomig A., and Preissner K.T. VLA-4 (alpha(4)beta(1)) engagement defines a novel activation pathway for beta(2) integrin-dependent leukocyte adhesion involving the urokinase receptor. Blood 96 (2000) 506-513
36. Sachs U.J., ndrei-Selmer C.L., Maniar A., Weiss T., Paddock C., Orlova V.V., et al. The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). J Biol Chem 282 (2007) 23603-23612